Investment Thesis
CS Diagnostics exhibits severe operational dysfunction with revenue of only $94.2K, negative operating cash flow of -$528K, and implausible balance sheet metrics (499.4M in assets with 1.6K liabilities) suggesting data integrity issues. The company demonstrates unprofitable cash generation despite reported net margins of 34.1%, indicating the operating profitability is illusory and the business model is fundamentally broken.
Strengths
- Strong reported net profit margin of 34.1%
- Zero debt and strong stated stockholders equity position
- Positive reported operating income of $32.1K
Risks
- Severe negative free cash flow of -$528K contradicts profitability claims, indicating cash burn despite reported profits
- Extremely limited revenue base of $94.2K indicates minimal business operations or severe business decline
- Implausible balance sheet with $499.4M assets against $1.6K liabilities and $13 cash suggests data quality issues or accounting abnormalities
- Zero insider activity in last 90 days indicates lack of management confidence or engagement
- Negative FCF margin of -0.6% demonstrates inability to generate positive cash despite operations
Key Metrics to Watch
- Operating cash flow trend and reconciliation with reported profitability
- Actual revenue growth and composition of asset base
- Insider transaction activity indicating management confidence
Financial Metrics
Revenue
94.2K
Net Income
32.1K
EPS (Diluted)
$0.00
Free Cash Flow
-528.0
Total Assets
499.4M
Cash
13.0
Profitability Ratios
Gross Margin
N/A
Operating Margin
34.1%
Net Margin
34.1%
ROE
0.0%
ROA
0.0%
FCF Margin
-0.6%
Balance Sheet & Liquidity
Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
0.00x
Debt/Assets
0.0%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-23T01:58:10.827438 |
Data as of: 2025-09-30 |
Powered by Claude AI